New FDA guidelines may benefit Triangle's drug research companies

New FDA guidelines may benefit Triangle's drug research companies

New federal guidelines that encourage the pharmaceutical industry to consider a non-traditional approach to monitoring clinical trials of experimental drugs could be a long-term plus for the Triangle's contract research organizations. The guidelines

2
Like
Save

Comments

Write a comment

*